Faeth Therapeutics, Inc. (FTH) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$17.70M2021: -$30.26M2022: -$39.03M2023: -$32.02M2024: -$24.67M2025: -$20.45M-$20.45M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$20.45M+17.1%
2024-$24.67M+23.0%
2023-$32.02M+17.9%
2022-$39.03M-29.0%
2021-$30.26M-70.9%
2020-$17.70M